Skip to main content

Month: July 2025

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Ongoing mpox outbreak continues to be a global health threat and is driving need for greater therapeutic research and innovation GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced the publication of a comprehensive review article, “Brincidofovir in the Era of Mpox,” in the peer-reviewed journal Expert Review of Anti-infective Therapy.1 This publication includes an overview of brincidofovir, in vitro and in vivo data, including human case studies of the investigational use of brincidofovir, the current evaluation for treating mpox infections in adults and pediatrics in the Democratic Republic of Congo, and the potential for combination therapy with tecovirimat for immunocompromised patients with severe disease.     “We believe in the importance of assessing brincidofovir,...

Continue reading

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announces its recognition of the U.S. House of Representatives for adding over-the-counter (OTC) naloxone to every AED location in its buildings, providing direct access to first responders and anyone coming across an individual who may be experiencing an opioid overdose. This effort has been led by Representative Buddy Carter (R-GA), with his team and congressional constituents, who have kept this public health issue a priority. Expanding access to potentially life-saving treatments is critical to saving more Americans and their families from an opioid overdose death. Emergent remains focused on saving lives through efforts to increase access, awareness and the availability of NARCAN® Nasal Spray 4 mg and KLOXXADO® Nasal Spray 8 mg....

Continue reading

Inception Growth Acquisition Limited Announces Adjournment of the Special Meeting to August 8, 2025 and Extension of Redemption Deadline

New York, July 28, 2025 (GLOBE NEWSWIRE) — On July 25, 2025, Inception Growth Acquisition Limited (the “Company”), a blank check company, previously announced that it convened its special meeting (“Special Meeting”) and immediately adjourned the Special Meeting, without conducting any business, to August 8, 2025. The Special Meeting was adjourned as to all of the proposals contained in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (“SEC”) on May 27, 2025, as supplemented by the supplement to the definitive proxy statement on June 26, 2025 (the “Proxy Statement”), including the proposal to approve the proposed business combination with AgileAlgo Holdings Ltd. Redemption Deadline Extended The Company would like to further clarify that as a result of the adjournment, the deadline for delivery...

Continue reading

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

ROCKVILLE, Md., July 28, 2025 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc., a Delaware corporation (NASDAQ: SUPN) (“Supernus“, and the “Company”), today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act“), with respect to Supernus’ proposed acquisition of Sage Therapeutics, Inc., a Delaware corporation (NASDAQ: SAGE) (“Sage“), expired at 11:59 p.m. Eastern Time on July 25, 2025. On June 13, 2025, Supernus and Sage, entered into an Agreement and Plan of Merger (the “Merger Agreement“), by and among Supernus, Sage and Saphire, Inc., a Delaware corporation and a wholly owned subsidiary of Supernus (“Purchaser“). On June 25, 2025 and June 30, 2025, Supernus and Sage, respectively,...

Continue reading

Savi Financial Corporation and SaviBank Provide Update to Shareholders Regarding Closing of Acquisition

MOUNT VERNON, Wash., July 28, 2025 (GLOBE NEWSWIRE) — Savi Financial Corporation, Inc. (OTC Pink: SVVB) (“Savi Financial” or the “Company”) and its wholly owned subsidiary, SaviBank, today announced that all parties have received final regulatory approval to complete the acquisition of SaviBank’s operating assets and the assumption of SaviBank’s deposits by Tacoma-based Harborstone Credit Union. The acquisition was announced on March 21, 2024, upon the parties’ entry into a Purchase and Assumption Agreement on that date. “We are delighted to have received our final approvals to allow the transaction to proceed to closing,” stated Michal D. Cann, Chairman and President of Savi Financial Corporation. “Although regulatory approval has taken longer than we had hoped, we are enthusiastic in that the approvals are not subject to any...

Continue reading

Skyline Bankshares, Inc. Announces Second Quarter 2025 Results

FLOYD, Va. and INDEPENDENCE, Va., July 28, 2025 (GLOBE NEWSWIRE) — Skyline Bankshares, Inc. (the “Company”) (OTC QX: SLBK) – the holding company for Skyline National Bank (the “Bank”) – announced its results of operations for the second quarter of 2025.   As previously announced, the Company acquired Johnson County Bank (“JCB”) on September 1, 2024, with the Company as the surviving corporation. For accounting purposes, the Company is considered the acquiror and JCB is considered the acquiree in the transaction. As such, all information contained herein as of and for periods prior to September 1, 2024 reflects the operations of the Company prior to the merger. The Company recorded net income of $3.8 million, or $0.68 per share, for the quarter ended June 30, 2025, compared to net income of $3.6 million, or $0.64 per share, for...

Continue reading

Synchronoss Technologies Announces Second Quarter 2025 Earnings Call Date

BRIDGEWATER, N.J., July 28, 2025 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, will hold a conference call on Monday, August 11, 2025 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the second quarter ended June 30, 2025. Financial results will be issued in a press release prior to the call. Synchronoss management will host the presentation, followed by a question-and-answer period. Date: Monday, August 11, 2025Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Dial-In Number: 877-451-6152 (domestic) or 201-389-0879 (international)Conference ID: 13754775 The conference call will be broadcast live here and via the Investor Relations section of Synchronoss’ website. About SynchronossSynchronoss...

Continue reading

BCB Bancorp, Inc. Earns $3.6 Million in Second Quarter 2025; Reports $0.18 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share

BAYONNE, N.J., July 28, 2025 (GLOBE NEWSWIRE) — BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported net income of $3.6 million for the second quarter of 2025, compared to a net loss of $8.3 million in the first quarter of 2025, and net income of $2.8 million for the second quarter of 2024. Earnings per diluted share for the second quarter was $0.18 compared to a loss of ($0.51) per diluted share in the preceding quarter and $0.14 in the second quarter of 2024. The Company also announced that its Board of Directors has declared a regular quarterly cash dividend of $0.16 per share. The dividend will be payable on August 25, 2025 to common shareholders of record on August 11, 2025. “We are pleased with the quarterly results that demonstrate that the core profitability...

Continue reading

Business First Bancshares, Inc., Announces Financial Results for Q2 2025

BATON ROUGE, La., July 28, 2025 (GLOBE NEWSWIRE) — Business First Bancshares, Inc. (NASDAQ: BFST) (Business First), parent company of b1BANK, today announced its unaudited results for the quarter ended June 30, 2025. Business First reported net income available to common shareholders of $20.8 million or $0.70 per diluted common share, increases of $1.6 million and $0.05, respectively, compared to the linked quarter ended March 31, 2025. On a non-GAAP basis, core net income for the quarter ended June 30, 2025, which excludes certain income and expenses, was $19.5 million or $0.66 per diluted common share, an increase of $0.2 million and $0.01, from the linked quarter. “Between our latest partnership announcement, successful core conversion and legacy branch repositioning, this was a quarter that positions us for continued growth...

Continue reading

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Increases total holdings to 1,535,772 HYPE Company to host investor webinar on Tuesday, July 29th at 2:00pm ET LAGUNA HILLS, Calif., July 28, 2025 (GLOBE NEWSWIRE) — Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced that it has acquired an additional 108,594 HYPE tokens, expanding its total holdings to 1,535,772 HYPE purchased at an average price of $36.14 per token. This latest purchase is in preparation of deploying HYPE into Kinetiq’s iHYPE (“Institutional HYPE”) pool, a gated smart contract environment that provides access to the iHYPE Liquid Staking Token (LST). iHYPE is available only for select institutional participants that complete KYB/AML verification and compliance onboarding. “Following the successful launch of our co-branded validator, we continued working closely with the Kinetiq...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.